EFFICACY AND SAFETY OF DIFFERENT DOSES OF RISANKIZUMAB IN CROHN DISEASE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引：0
|
作者：
Badi, Yasra
Hammad, Mohamed
Mohamed, Mujtaba
Elghezewi, Abdelwahap
Kamal, Ibrahim
Fathallah, Ahmed H.
Gamal, Mohamed H.
Ragab, Khaled M.
Sultan, Mohamed
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1133
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis
    Hua-Hua Yang
    Yi Huang
    Xu-Chun Zhou
    Ruo-Nan Wang
    World Journal of Clinical Cases, 2022, (18) : 6091 - 6104
  • [22] Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn's disease
    Qiu, Yun
    Li, Man-ying
    Feng, Ting
    Feng, Rui
    Mao, Ren
    Chen, Bai-li
    He, Yao
    Zeng, Zhi-rong
    Zhang, Sheng-hong
    Chen, Min-hu
    STEM CELL RESEARCH & THERAPY, 2017, 8
  • [23] Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysis
    Chandar, Apoorva K.
    Singh, Siddharth
    Murad, Mohammad Hassan
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (07) : 1695 - 1708
  • [24] Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease
    Yun Qiu
    Man-ying Li
    Ting Feng
    Rui Feng
    Ren Mao
    Bai-li Chen
    Yao He
    Zhi-rong Zeng
    Sheng-hong Zhang
    Min-hu Chen
    Stem Cell Research & Therapy, 8
  • [25] Safety profile of biologic drugs in the therapy of Crohn disease: A systematic review and network meta-analysis
    Mocko, Pawel
    Kawalec, Pawel
    Pilc, Andrzej
    PHARMACOLOGICAL REPORTS, 2016, 68 (06) : 1237 - 1243
  • [26] Safety profile of biologic drugs in the therapy of Crohn disease: A systematic review and network meta-analysis
    Paweł Moćko
    Paweł Kawalec
    Andrzej Pilc
    Pharmacological Reports, 2016, 68 : 1237 - 1243
  • [27] Efficacy and prognosis of adalimumab for Crohn's disease at different disease locations: a systematic review and meta-analysis
    Yu, W-L
    Hua, Z-C
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (06) : 2036 - 2048
  • [28] EFFICACY OF RISANKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS:A SYSTEMATIC REVIEW AND META-ANALYSIS
    Zhou, H.
    Xia, G. M.
    Su, C.
    Tian, H. Y.
    Deng, Y. J.
    Wang, X. M.
    Ren, J. Y.
    Shen, R. T.
    Su, Q. Y.
    Yu, Q.
    He, P. F.
    Li, X.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1781 - 1781
  • [29] Efficacy and safety of medical therapies for maintenance of surgically induced remission in Crohn's disease: A systematic review and network meta-analysis
    Sinopoulou, V.
    Gordon, M.
    Vuyyuru, S.
    Darie, A. M.
    Limdi, J.
    Moran, G.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1400 - I1400
  • [30] Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis
    Singh, Siddharth
    Murad, M. Hassan
    Fumery, Mathurin
    Sedano, Rocio
    Jairath, Vipul
    Panaccione, Remo
    Sandborn, William J.
    Ma, Christopher
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 1002 - 1014
12345